Expression of DPC4/Smad4 gene in stone-containing intrahepatic bile duct

被引:17
作者
Lee, King-Teh
Chang, Wen-Tsan
Wang, Shen-Nien
Chuang, Shih-Chang
Chai, Chee-Yin
Hu, Shih-Wen
机构
[1] Kaohsiung Med Univ, Chung Ho Mem Hosp, Dept Surg, Div Hepatol Surg, Kaohsiung 807, Taiwan
[2] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Surg, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ, Chung Ho Mem Hosp, Dept Pathol, Kaohsiung, Taiwan
关键词
DPC4/Smad4; gene; hepatolithiasis; cholangiocarcinoma; intrahepatic bile duct;
D O I
10.1002/jso.20517
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Background and Objectives: Hepatolithiasis is etiologically related to cholangiocarcinoma. We underwent this study with an attempt to examine the expression of DPC4/Smad4 gene in stone-containing intrahepatic bile ducts (IHD) and intrahepatic cholangiocarcinoma (ICC). Patients and Methods: The immunohistochemical method and RT-PCR analysis were used to study the expression of DPC4/Smad4 gene in normal IHD, stone-containing IHD, and ICC. All the specimens were from hepatic resection. Results: The immunohistochemical study showed that all specimens from 24 normal IHD had marked expression of DPC4/Smad4 gene, while there was 4.4% (2/46) and 33.3% (3/9) loss of DPC4/Smad4 expression in stone-containing IHD and ICC, respectively. Among the specimens of stone-containing IHD, all the hyperplastic epithelial cells showed normal expression of DPC4/Smad4 gene while dysplastic epithelial cells showed 20% (2/10) loss expression of DPC4/Smad4. The RT-PCR analysis showed that the normal IHD had the highest content of DPC4/Smad4 mRNA, which was threefold and sixfold higher than that of stone-containing IHD and ICC, respectively. Conclusion: Loss expression of DPC4/Smad4 gene was found both in stone-containing IHD and ICC. Dysplastic epithelium of stone-containing IHD had higher potential for malignant transformation.
引用
收藏
页码:338 / 343
页数:6
相关论文
共 28 条
[1]
Argani P, 2001, CANCER, V91, P1332
[2]
BALDUS SE, 2004, ONCOGENE, V23, P1
[3]
Barrett MT, 1996, CANCER RES, V56, P4351
[4]
CHEN MF, 1993, CANCER, V71, P2461, DOI 10.1002/1097-0142(19930415)71:8<2461::AID-CNCR2820710806>3.0.CO
[5]
2-7
[6]
Immunohistochemical study of DPC4 and P53 proteins in gallbladder and bile duct cancers [J].
Chuang, SC ;
Lee, KT ;
Tsai, KB ;
Sheen, PC ;
Nagai, E ;
Mizumoto, K ;
Tanaka, M .
WORLD JOURNAL OF SURGERY, 2004, 28 (10) :995-1000
[7]
Expression of transforming growth factor β receptors in normal human colon and sporadic adenocarcinomas [J].
Eskinazi, R ;
Resibois, A ;
Svoboda, M ;
Peny, MO ;
Adler, M ;
Robberecht, P ;
Van Laethem, JL .
GASTROENTEROLOGY, 1998, 114 (06) :1211-1220
[8]
ENHANCED EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA ISOFORMS IN PANCREATIC-CANCER CORRELATES WITH DECREASED SURVIVAL [J].
FRIESS, H ;
YAMANAKA, Y ;
BUCHLER, M ;
EBERT, M ;
BEGER, HG ;
GOLD, LI ;
KORC, M .
GASTROENTEROLOGY, 1993, 105 (06) :1846-1856
[9]
Hahn SA, 1998, CANCER RES, V58, P1124
[10]
HANN SA, 1996, SCIENCE, V271, P350